CVN424

CVN424 · Cerevance Beta, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CVN424, covering 2024-07-03 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications [Phase 3]